Glofitamab with Polatuzumab Vedotin in Refractory Burkitt’s Lymphoma - Anca Prica; Mark Roschewski; Peter Beale; Stefania Pittaluga; Jan Delabie; Claudia Ortega; Robert Kridel (New England Journal of Medicine, 2025)